Cargando…
The Role of Heparin in COVID-19: An Update after Two Years of Pandemics
Coronavirus disease 2019 (COVID-19) is associated with an increased risk of venous thromboembolism (VTE) and coagulopathy, especially in critically ill patients. Endothelial damage induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is emerging as a crucial pathogenetic mechanism...
Autores principales: | Mangiafico, Marco, Caff, Andrea, Costanzo, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180990/ https://www.ncbi.nlm.nih.gov/pubmed/35683485 http://dx.doi.org/10.3390/jcm11113099 |
Ejemplares similares
-
Heparin-induced thrombocytopenia: an update
por: Franchini, Massimo
Publicado: (2005) -
Horizons of Heparin Therapy in COVID-19 and Pandemic-Related Diseases
por: Kondashevskaya, M. V.
Publicado: (2022) -
Coagulopathy, thromboembolic complications, and the use of heparin in COVID-19 pneumonia
por: Costanzo, Luca, et al.
Publicado: (2020) -
Rationale for the Role of Heparin and Related GAG Antithrombotics in COVID-19 Infection
por: Magnani, Harry N.
Publicado: (2021) -
COVID-19 pandemic: An update on the reaction attitude of the spine societies and their members worldwide
por: Ramieri, Alessandro, et al.
Publicado: (2022)